Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
193.62
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
453
Open
193.62
Bid (Size)
193.00 (2)
Ask (Size)
194.20 (3)
Prev. Close
193.62
Today's Range
193.62 - 193.62
52wk Range
135.85 - 199.95
Shares Outstanding
N/A
Dividend Yield
3.06%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
September 19, 2024
Via
Benzinga
2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure?
September 19, 2024
Pharma stock have been on the rise in the latter half of the year, but the 2024 election remains a wild card for shares.
Via
Investor's Business Daily
Performance
YTD
+21.15%
+21.15%
1 Month
-1.29%
-1.29%
3 Month
+12.48%
+12.48%
6 Month
+9.08%
+9.08%
1 Year
+26.05%
+26.05%
More News
Read More
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
September 19, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Abbie Inc Stocks Elliott Wave Technical Analysis - Wednesday, September 18,
September 18, 2024
Via
Talk Markets
Is ABBVIE INC Ready to Break Out of Its Range?
September 17, 2024
Via
Chartmill
TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades'
September 17, 2024
Via
Benzinga
Topics
ETFs
What the Options Market Tells Us About AbbVie
September 11, 2024
Via
Benzinga
Spotlight on AbbVie: Analyzing the Surge in Options Activity
September 09, 2024
Via
Benzinga
Peering Into AbbVie's Recent Short Interest
September 06, 2024
Via
Benzinga
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
September 16, 2024
Via
The Motley Fool
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
September 14, 2024
Via
The Motley Fool
3 Stocks to Buy and Hold Forever
September 14, 2024
Via
The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
September 14, 2024
Via
The Motley Fool
Time To Invest And Or Trade In Bio-Tech Stocks?
September 13, 2024
Via
Talk Markets
Topics
ETFs
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
September 05, 2024
Via
Benzinga
Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
September 13, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
September 11, 2024
Via
Benzinga
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
September 10, 2024
Via
Benzinga
3 Things You Need to Know if You Buy AbbVie Stock Today
September 09, 2024
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy in September
September 08, 2024
Via
The Motley Fool
Earn $1,000 Per Month in Dividends From These 4 Stocks
September 07, 2024
Via
The Motley Fool
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever
September 05, 2024
Via
The Motley Fool
AbbVie Stock Post Humira is Still an Attractive Stock to Hold
September 04, 2024
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
Via
FinancialNewsMedia
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.